Autologous CD19 CAR-T cell therapy with inducible safety switch
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous CD19 CAR-T cell therapy with inducible safety switch, covering 2025-10-27 to 2025-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL [Phase 1, Phase 2]